by Dolly the Sheep | Nov 21, 2018 | Stem Cell, Technology
Chapter 4: Chemical Transdifferentiation Regenerative medicine, which can replace lost or damaged cells in a variety of tissues and organs, requires sufficient amounts of the desired competent cells for transplantation. Such cells can be obtained by the reprogramming...
by Dolly the Sheep | Nov 21, 2018 | Stem Cell, Technology
Chapter 3: Chemically Induced Pluripotent Stem Cell The use of human embryonic stem cells (hESCs) in research and for therapeutic applications is a controversial issue due to a combination of religious, political and ethical considerations. This led researchers to...
by Dolly the Sheep | Nov 21, 2018 | Stem Cell, Technology
Chapter 2: Improving Reprogramming Efficiency Induced pluripotent stem cells (iPSCs) hold several advantages over embryonic stem cells (ESCs), including avoiding the ethical issues involved with ESCs, the availability of an “endless” cells source and the ability to...
by Dolly the Sheep | Nov 21, 2018 | Stem Cell, Technology
Chapter 1: Stem Cell Maintenance and Self-renewal In order to maintain the pluripotency of embryonic stem cells (ESCs), they are commonly cultured in the presence of feeder cells, serum and growth factors. Growth factors related to crucial signaling pathways involved...
by Dolly the Sheep | Nov 13, 2018 | News, Stem Cell, Technology
Kyoto University has conducted the world’s first induced pluripotent stem cells (iPSC) transplant in an attempt to treat Parkinson’s disease. Parkinson’s disease is due to the loss of brain cells that produce dopamine. Parkinson’s disease symptoms...
